New molecule could reverse neurodegeneration in Parkinson’s

News

Author: Simge Eva DoganPublished: 11 October 2018

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

molecule

Researchers at a university in Spain have discovered a new molecule which they claim can block and reverse neurodegeneration in Parkinson’s.

The molecule – named SynuClean-D – is able to reduce alpha-synuclein aggregations which cause degeneration.

The study – published in science journal ‘PNAS’ – explains how researchers at the Universitat Autònoma de Barcelona, Spain, tested over 14,000 molecules before discovering SynuClean-D.

They then tested the molecule on a Caenorhabditis worm – one of the most commonly used animals when researching neurodegenerative diseases – finding that it boosted its mobility and protected it from neural degeneration.

Salvador Ventura, the study coordinator, said: “Everything seems to indicate that the molecule we identified, the SynuClean-D, may provide therapeutic applications for the treatment of neurodegenerative diseases such as Parkinson’s in the future.”

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the EPDA website.

Go Back

Share this story

Comments


Related articles


170426_PL_Unity Walk New York lead

Global update

Every step counts: New York Unity Walk raises more than $1m for Parkinson’s

Twenty-third edition of world’s largest Unity Walk attracts 10,000

READ MORE

Europe

Walk with Copenhagen

Join the Danish Parkinson Association for their annual event

READ MORE
A doctor using a tablet computer in a patient's discussion

Health & Fitness

Sexuality, intimacy and Parkinson’s: getting help

How to seek professional help for sexual issues in Parkinson’s

READ MORE